相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。POSC202 Estimated Migraine Patient Population in England Progressing Beyond First-Line Acute Management
L Harris et al.
VALUE IN HEALTH (2022)
A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine
Saval Khanal et al.
JOURNAL OF HEADACHE AND PAIN (2022)
Trends in utilization and costs of migraine medications, 2017-2020
Jennifer L. Nguyen et al.
JOURNAL OF HEADACHE AND PAIN (2022)
GBD 2016 Headache Collaborators. Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 (vol 17, pg 954, 2018)
Ali H. Mokdad
LANCET NEUROLOGY (2021)
A Framework for Estimating the Eligible Patient Population for New Migraine Acute Therapies in the United States
Linda Harris et al.
ADVANCES IN THERAPY (2021)
Indirect Comparison of Topiramate and Monoclonal Antibodies Against CGRP or Its Receptor for the Prophylaxis of Episodic Migraine: A Systematic Review with Meta-Analysis
Lucas Hendrik Overeem et al.
CNS DRUGS (2021)
The American Headache Society Consensus Statement: Update on integrating new migraine treatments into clinical practice
Jessica Ailani et al.
HEADACHE (2021)
Real-life data on the efficacy and safety of erenumab in the Abruzzo region, central Italy
Raffaele Ornello et al.
JOURNAL OF HEADACHE AND PAIN (2020)
Economic evaluations in migraine: systematic literature review and a novel approach
Ronan Mahon et al.
JOURNAL OF MEDICAL ECONOMICS (2020)
Updated Evaluation of IV Dihydroergotamine (DHE) for Refractory Migraine: Patient Selection and Special Considerations
Rafia Shafqat et al.
JOURNAL OF PAIN RESEARCH (2020)
Guidelines for controlled trials of preventive treatment of migraine attacks in episodic migraine in adults
Hans-Christoph Diener et al.
CEPHALALGIA (2020)
Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine
Jennifer Robblee et al.
HEADACHE (2020)
Migraine day frequency in migraine prevention: longitudinal modelling approaches
Gian Luca Di Tanna et al.
BMC MEDICAL RESEARCH METHODOLOGY (2019)
Effect of a rescue or recurrence dose of lasmiditan on efficacy and safety in the acute treatment of migraine: findings from the phase 3 trials (SAMURAI and SPARTAN)
Li Shen Loo et al.
BMC NEUROLOGY (2019)
Effect of Ubrogepant vs Placebo on Pain and the Most Bothersome Associated Symptom in the Acute Treatment of Migraine The ACHIEVE II Randomized Clinical Trial
Richard B. Lipton et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Costs of Acute Headache Medication Use and Productivity Losses Among Patients with Migraine: Insights from Three Randomized Controlled Trials
Joshua K. Porter et al.
PHARMACOECONOMICS-OPEN (2019)
Headache Classification Committee of the International Headache Society (IHS) The International Classification of Headache Disorders, 3rd edition
Jes Olesen
CEPHALALGIA (2018)
The Prevalence and Impact of Migraine and Severe Headache in the United States: Figures and Trends From Government Health Studies
Rebecca Burch et al.
HEADACHE (2018)
Estimating, the clinical effectiveness and value-based price range of erenumab for the prevention of migraine in patients with prior treatment failures: a US societal perspective
Richard B. Lipton et al.
JOURNAL OF MEDICAL ECONOMICS (2018)
Health care Resource Utilization and Migraine Disability Along the Migraine Continuum Among Patients Treated for Migraine
Stephen D. Silberstein et al.
HEADACHE (2018)
Global, regional, and national burden of meningitis, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Joseph Raymond Zunt et al.
LANCET NEUROLOGY (2018)
Global, regional, and national burden of migraine and tension-type headache, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Lars Jacob Stovner et al.
LANCET NEUROLOGY (2018)
When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month
M. Torres-Ferrus et al.
CEPHALALGIA (2017)
Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016
Theo Vos et al.
LANCET (2017)
Safety and efficacy of erenumab for preventive treatment of chronic migraine: a randomised, double-blind, placebo-controlled phase 2 trial
Stewart Tepper et al.
LANCET NEUROLOGY (2017)
A Controlled Trial of Erenumab for Episodic Migraine
Peter J. Goadsby et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prevalence and Medical Costs of Chronic Diseases Among Adult Medicaid Beneficiaries
John M. Chapel et al.
AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2017)
Safety and efficacy of AMG 334 for prevention of episodic migraine: a randomised, double-blind, placebo-controlled, phase 2 trial
Hong Sun et al.
LANCET NEUROLOGY (2016)
Triptans in the Acute Treatment of Migraine: A Systematic Review and Network Meta-Analysis
Chris Cameron et al.
HEADACHE (2015)
General cardiovascular risk profile for use in primary care - The Framingham Heart Study
Ralph B. D'Agostino et al.
CIRCULATION (2008)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
分享论文
